KELSEY WRIGHT: Open Payments
NPI 1326515529 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 58 payments from 14 companies in 2025. Trend: 2023 $392 · 2024 $960 · 2025 $1,440
Food & beverage: $1,373Education: $67
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 16 | $481 |
| Regeneron Healthcare Solutions, Inc. | 4 | $199 |
| ABBVIE INC. | 11 | $198 |
| Janssen Biotech, Inc. | 6 | $188 |
| UCB, Inc. | 4 | $85 |
| Lilly USA, LLC | 4 | $73 |
| Arcutis Biotherapeutics, Inc. | 4 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $21 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Bimzelx, Zoryve, TALTZ.
Industry payments across KY — which companies pay providers there.
